Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Calcineurin, a calmodulin-stimulated
protein phosphatase
, was a substrate for purified bovine brain protein carboxyl O-
methyltransferase
(protein O-methyltransferase; EC 2.1.1.24) and incorporated up to 2 mol of CH3 per mol of
calcineurin
. Carboxyl methylation was dependent on the concentrations of S-adenosyl-L-[methyl-3H]methionine and was prevented by addition of the carboxyl methylation inhibitor S-adenosylhomocysteine. The stoichiometry of methyl group incorporation was related to the ratio of
methyltransferase
/
calcineurin
. The rate of spontaneous hydrolysis of carboxyl methylester groups on
calcineurin
increased rapidly above pH 6.5 with those on native carboxyl-methylated
calcineurin
substantially more labile than for trichloracetic acid-precipitated
calcineurin
. Polyacrylamide gel electrophoresis in the presence of NaDodSO4 (pH 2.4) confirmed that the A subunit of
calcineurin
(Mr = 61,000) was the primary site of carboxyl methylation with little, if any, modification of the B subunit (Mr = 18,000). When carboxyl-methylated
calcineurin
(approximately 1-2 mol of CH3 per mol of protein) was assayed for p-nitrophenyl phosphatase activity at pH 6.5, a marked inhibition of calmodulin-stimulated activity was observed while there was little effect on Mn2+-stimulated phosphatase activity. Thus,
calcineurin
appears to be an excellent substrate for protein carboxyl O-methylation and this modification, which impairs calmodulin stimulation of phosphatase activity, may be of functional significance.
...
PMID:Stoichiometric methylation of calcineurin by protein carboxyl O-methyltransferase and its effects on calmodulin-stimulated phosphatase activity. 299 37
The catalytic C subunit of
protein phosphatase
2A2 was methylated with an apparent km of about 0.1 microM by purified preparations of a
methyltransferase
from bovine brain. This methylation was inhibited by okadaic acid and microcystin-LR half-maximally at 40 nM and 60 nM, respectively. The extent of inhibition depended on the
protein phosphatase
concentration in the incubations, but was independent of the
methyltransferase
concentration. The results demonstrate that okadaic acid and microcystin-LR directly inhibit the methylation of protein phosphatase 2A. The results are consistent with the idea that okadaic acid and microcystin-LR act, at least in part, by binding to the carboxyl terminus of the C subunit of protein phosphatase 2A thereby preventing access of the
methyltransferase
to its target site, the C subunit carboxyl terminal Leu309.
...
PMID:Okadaic acid and microcystin-LR directly inhibit the methylation of protein phosphatase 2A by its specific methyltransferase. 804 14
We have recently described a novel protein carboxyl methylation system that results in the reversible modification of a 36-kDa polypeptide component of a 178-kDa protein in the cytosol of a variety of eucaryotic cells. This reaction, catalyzed by a cytosolic 40-kDa methyl-transferase, results in the methyl esterification of the alpha-carboxyl group of the C-terminal leucine residue. We have now purified the major methylated 36-kDa polypeptide from bovine brain. N-terminal sequence analysis of a tryptic fragment of this polypeptide revealed identity to the catalytic subunit of protein phosphatase 2A. This enzyme exists in the cell predominantly as a trimeric 151-kDa native species containing the 36-kDa catalytic polypeptide that terminates in a leucine residue. We then fractionated bovine brain cytosolic extracts to separate the major phosphatase isoforms 2A1 and 2A2 and found that both could be methylated by a partially purified preparation of the
methyltransferase
. A synthetic C-terminal octapeptide based on the sequence of the 36-kDa catalytic subunit is neither a substrate nor an inhibitor of this
methyltransferase
, suggesting that this enzyme recognizes aspects of the tertiary and/or quaternary structure of the native phosphatase. Because this modification reaction is readily reversible in extracts, it may represent a novel strategy of the cell to modulate the function of this
protein phosphatase
.
...
PMID:Protein phosphatase 2A is reversibly modified by methyl esterification at its C-terminal leucine residue in bovine brain. 829 50
Phosphoprotein
phosphatase 2A
(
PP2A
) is one of the four major protein serine/threonine phosphatases found in all eukaryotic cells. We have shown that the 36-kDa catalytic subunit of
PP2A
is carboxyl methylated in eukaryotic cells, and we have previously identified and purified a novel
methyltransferase
(MTase) that is responsible for this modification. Here, we describe a novel protein carboxyl methyl-esterase (MEase) from bovine brain that demethylates
PP2A
. The enzyme has been purified to homogeneity as a monomeric 46-kDa soluble protein. The MEase is highly specific for
PP2A
. It does not catalyze the demethylation of other protein or peptide methylesters. Moreover, MEase activity is dramatically inhibited by nanomolar concentrations of okadaic acid, a specific inhibitor of
PP2A
. From these results, we conclude that
PP2A
methylation is controlled by two specific enzymes, a MTase and a MEase. Since
PP2A
methylation is highly conserved in eukaryotes ranging from human to yeast, it is likely that this system plays an important role in phosphatase regulation.
...
PMID:A specific protein carboxyl methylesterase that demethylates phosphoprotein phosphatase 2A in bovine brain. 865 Feb 16
Carboxymethylation of proteins is a highly conserved means of regulation in eukaryotic cells. The protein phosphatase 2A (
PP2A
) catalytic (C) subunit is reversibly methylated at its carboxyl terminus by specific
methyltransferase
and methylesterase enzymes which have been purified, but not cloned. Carboxymethylation affects
PP2A
activity and varies during the cell cycle. Here, we report that substitution of glutamine for either of two putative active site histidines in the
PP2A
C subunit results in inactivation of
PP2A
and formation of stable complexes between
PP2A
and several cellular proteins. One of these cellular proteins, herein named protein phosphatase methylesterase-1 (PME-1), was purified and microsequenced, and its cDNA was cloned. PME-1 is conserved from yeast to human and contains a motif found in lipases having a catalytic triad-activated serine as their active site nucleophile. Bacterially expressed PME-1 demethylated
PP2A
C subunit in vitro, and okadaic acid, a known inhibitor of the
PP2A
methylesterase, inhibited this reaction. To our knowledge, PME-1 represents the first mammalian protein methylesterase to be cloned. Several lines of evidence indicate that, although there appears to be a role for C subunit carboxyl-terminal amino acids in PME-1 binding, amino acids other than those at the extreme carboxyl terminus of the C subunit also play an important role in PME-1 binding to a catalytically inactive mutant.
...
PMID:A protein phosphatase methylesterase (PME-1) is one of several novel proteins stably associating with two inactive mutants of protein phosphatase 2A. 1031 62
Protein
phosphatase 2A
(
PP2A
) is an essential eukaryotic serine/threonine phosphatase known to play important roles in cell cycle regulation. Association of different B-type targeting subunits with the heterodimeric core (A/C) enzyme is known to be an important mechanism of regulating
PP2A
activity, substrate specificity, and localization. However, how the binding of these targeting subunits to the A/C heterodimer might be regulated is unknown. We have used the budding yeast Saccharomyces cerevisiae as a model system to investigate the hypothesis that covalent modification of the C subunit (Pph21p/Pph22p) carboxyl terminus modulates
PP2A
complex formation. Two approaches were taken. First, S. cerevisiae cells were generated whose survival depended on the expression of different carboxyl-terminal Pph21p mutants. Second, the major S. cerevisiae
methyltransferase
(Ppm1p) that catalyzes the methylation of the
PP2A
C subunit carboxyl-terminal leucine was identified, and cells deleted for this
methyltransferase
were utilized for our studies. Our results demonstrate that binding of the yeast B subunit, Cdc55p, to Pph21p was disrupted by either acidic substitution of potential carboxyl-terminal phosphorylation sites on Pph21p or by deletion of the gene for Ppm1p. Loss of Cdc55p association was accompanied in each case by a large reduction in binding of the yeast A subunit, Tpd3p, to Pph21p. Moreover, decreased Cdc55p and Tpd3p binding invariably resulted in nocodazole sensitivity, a known phenotype of CDC55 or TPD3 deletion. Furthermore, loss of methylation also greatly reduced the association of another yeast B-type subunit, Rts1p. Thus, methylation of Pph21p is important for formation of
PP2A
trimeric and dimeric complexes, and consequently, for
PP2A
function. Taken together, our results indicate that methylation and phosphorylation may be mechanisms by which the cell dynamically regulates
PP2A
complex formation and function.
...
PMID:Carboxymethylation of the PP2A catalytic subunit in Saccharomyces cerevisiae is required for efficient interaction with the B-type subunits Cdc55p and Rts1p. 1103 66
The
phosphoprotein phosphatase
2A (
PP2A
) catalytic subunit contains a methyl ester on its C-terminus, which in mammalian cells is added by a specific carboxyl methyltransferase and removed by a specific carboxyl methylesterase. We have identified genes in yeast that show significant homology to human carboxyl methyltransferase and methylesterase. Extracts of wild-type yeast cells contain carboxyl methyltransferase activity, while extracts of strains deleted for one of the
methyltransferase
genes, PPM1, lack all activity. Mutation of PPM1 partially disrupts the
PP2A
holoenzyme in vivo and ppm1 mutations exhibit synthetic lethality with mutations in genes encoding the B or B' regulatory subunit. Inactivation of PPM1 or overexpression of PPE1, the yeast gene homologous to bovine methylesterase, yields phenotypes similar to those observed after inactivation of either regulatory subunit. These phenotypes can be reversed by overexpression of the B regulatory subunit. These results demonstrate that Ppm1 is the sole
PP2A
methyltransferase
in yeast and that its activity is required for the integrity of the
PP2A
holoenzyme.
...
PMID:Carboxyl methylation of the phosphoprotein phosphatase 2A catalytic subunit promotes its functional association with regulatory subunits in vivo. 1106 18
Phosphoprotein
phosphatase 2A
(
PP2A
) is a major phosphoserine/threonine
protein phosphatase
in all eukaryotes. It has been isolated as a heterotrimeric holoenzyme composed of a 65 kDa A subunit, which serves as a scaffold for the association of the 36 kDa catalytic C subunit, and a variety of B subunits that control phosphatase specificity. The C subunit is reversibly methyl esterified by specific
methyltransferase
and methylesterase enzymes at a completely conserved C-terminal leucine residue. Here we show that methylation plays an essential role in promoting
PP2A
holoenzyme assembly and that demethylation has an opposing effect. Changes in methylation indirectly regulate
PP2A
phosphatase activity by controlling the binding of regulatory B subunits to AC dimers.
...
PMID:Carboxyl methylation regulates phosphoprotein phosphatase 2A by controlling the association of regulatory B subunits. 1106 19
The relationship between toxigenicity and phylogeny within the cyanobacterial genus Microcystis is unclear. To investigate this issue, we have designed PCR primers for the N-
methyltransferase
(NMT) domain of the microcystin synthetase gene mcyA and have probed 37 Microcystis sp. cultures as well as several field samples. The NMT region was present in all 18 laboratory strains that gave positive reactions in the
protein phosphatase
inhibition assay for microcystin but was absent in 17 nontoxic strains. Two other nontoxic strains, one of which had previously been reported to produce microcystin, possessed the NMT region. Detection of NMT-specific DNA in field samples corresponded to periods of toxicity as assessed by
protein phosphatase
inhibition. The Microcystis strains formed a monophyletic cluster based on 16S rRNA gene sequences but comprised two groups with respect to phycocyanin intergenic spacer (PC-IGS) sequences. Toxic and nontoxic strains appeared to be erratically distributed within the PC-IGS and 16S rRNA trees. Sequence analysis of the NMT domain revealed two coherent groups. The genomic region immediately downstream of the mcyABC cluster in all 20 NMT-positive strains contained an open reading frame of unknown function (uma1) at a conserved distance from mcyC. All nontoxic strains also contained uma1, which is not cotranscribed with mcyABC. The consistent linkage of mcyC to uma1 suggests that mcyC has not been frequently transferred into nontoxic strains via any mechanism involving insertion at random chromosomal locations. These results are discussed with respect to various mechanisms that could explain the patchy distribution of toxigenicity among the various Microcystis clades.
...
PMID:Detection of toxigenicity by a probe for the microcystin synthetase A gene (mcyA) of the cyanobacterial genus Microcystis: comparison of toxicities with 16S rRNA and phycocyanin operon (Phycocyanin Intergenic Spacer) phylogenies. 1137 98
Protein
phosphatase 2A
(
PP2A
) is a major threonine/serine phosphatase that is involved in regulating a variety of cellular processes. It has been shown in both yeast and mammals that the
PP2A
catalytic subunit (PP2Ac) is methyl-esterified at the conserved C-terminal Leu residue. The recent characterization of a mammalian
PP2A
carboxyl methyltransferase has led to the identification of two ORFs in Saccharomyces cerevisiae as potential orthologues of the mammalian
PP2A
methyltransferase
: protein phosphatase methyltransferase 1 (PPM1) and
protein phosphatase
methyltransferase
2 (PPM2). To experimentally identify the
PP2A
methyltransferase
in yeast, we obtained deletion mutants of PPM1 and PPM2 and then constructed double mutants. Using in vivo-labeling techniques, we demonstrate that only the PPM1 gene is required for PP2Ac methylation at the C-terminus. Because yeast has at least three homologues of PP2Ac (PPH21, PPH22, and PPH3), we then asked whether all of these catalytic subunits are methylated by the PPM1 and/or PPM2 putative methyltransferases. We modified the segment corresponding to the N-terminal coding region of all three PP2Ac genomic genes with a hemagglutinin (HA) tag in the parent, ppm1, ppm2, and ppm1ppm2 mutant genetic backgrounds. Using immuoprecipitation with anti-HA antibodies followed by methyl ester analysis, we showed that only in the ppm1 mutant were both Pph21p and Pph22p not methylated. We did not detect any methylesterification of Pph3p under our conditions. Our results indicate that PPM1 is the sole
methyltransferase
responsible for methylating the two major homologues of PP2Ac in yeast. The function of the PPM2 gene product remains unclear.
...
PMID:Protein phosphatase methyltransferase 1 (Ppm1p) is the sole activity responsible for modification of the major forms of protein phosphatase 2A in yeast. 1169 62
1
2
3
4
Next >>